Revolution Medicines, Inc. files DEF 14A

Revolution Medicines, Inc. is holding its 2026 Annual Meeting of Stockholders on June 18, 2026, to elect two Class III directors, ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026, and approve, on a non-binding advisory basis, the compensation of its named executive officers. The Board of Directors recommends a "FOR" vote for all proposals.